Catalyst Wire Dossier Catalyst Wire Dossier

CAR-T cell therapy (Galapagos)

· Galapagos NV
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR-T cell therapy (Galapagos), covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies [Phase 3]

See pricing